Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Atherosclerosis and Cardiovascular Diseases

TopicLeading institutions, researchers & key papers

Atherosclerosis and Cardiovascular Diseases is a topic indexed in ScholarIQ from OpenAlex.

What is known about Atherosclerosis and Cardiovascular Diseases?

ScholarIQrecord summary

This cluster of papers focuses on the immunological mechanisms involved in the development and progression of atherosclerosis. It covers topics such as the role of immune response, inflammation, oxidized LDL, regulatory T cells, cytokines, dendritic cells, adaptive immunity, and the LOX-1 receptor in atherosclerosis. The papers explore how T cell activation and B cell responses contribute to the pathogenesis of atherosclerosis.

How many works does Atherosclerosis and Cardiovascular Diseases have?

ScholarIQindexed works

Atherosclerosis and Cardiovascular Diseases has 291 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Atherosclerosis and Cardiovascular Diseases?

ScholarIQopenalex

The OpenAlex for Atherosclerosis and Cardiovascular Diseases is on the source record.

What are the most-cited papers on Atherosclerosis and Cardiovascular Diseases?

ScholarIQmost cited works
Atherosclerosis
Peter Libby, Julie E. Buring, Lina Badimón, Göran K. Hansson, John Deanfield, Márcio Sommer Bittencourt, Lâle Tokgözoğlu, Eldrin F. Lewis
Nature Reviews Disease Primers. 20193,067 Citations
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Francesco Paneni, Joshua A. Beckman, Mark A. Creager, Francesco Cosentino
European Heart Journal. 20131,419 CitationsOPEN ACCESS
Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction
Kouichi Ozaki, Yozo Ohnishi, Aritoshi Iida, A. Sekine, Ryo Yamada, Tatsuhiko Tsunoda, Hiroshi Sato, Hideyuki Sato, Masatsugu Hori, Yusuke Nakamura, Toshihiro Tanaka
Nature Genetics. 2002968 Citations
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Sotirios Tsimikas, Emmanouil S. Brilakis, Elizabeth R. Miller, Joseph P. McConnell, Ryan J. Lennon, Kenneth S. Kornman, Joseph L. Witztum, Peter B. Berger
New England Journal of Medicine. 2005776 CitationsOPEN ACCESS
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans
Fleur M. van der Valk, Siroon Bekkering, Jeffrey Kroon, Calvin Yeang, Jan Van den Bossche, Jaap D. van Buul, Amir Ravandi, Aart J. Nederveen, Hein J. Verberne, Corey A. Scipione, Max Nieuwdorp, Leo A. B. Joosten, Mihai G. Netea, Marlys L. Koschinsky, Joseph L. Witztum, Sotirios Tsimikas, Niels P. Riksen, Erik S.G. Stroes
Circulation. 2016660 CitationsOPEN ACCESS

Where is Atherosclerosis and Cardiovascular Diseases research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Atherosclerosis and Cardiovascular Diseases is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
13%
Hybrid
7%
Bronze
40%
Closed
40%

Related on ScholarIQ

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paper
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Paper
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Paper
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Paper
Atherosclerosis
Paper
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
Paper
470M+ articles · 14-day free trial